Phase II Single-arm Study Evaluating Neo-adjuvant (Pre-radical Radiotherapy) Abiraterone Acetate (Plus Prednisolone) and Gonadotropin-Releasing Hormone (GnRH) Agonist in High Risk Localised Prostate Carcinoma
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Abiraterone acetate (Primary) ; Prednisolone
- Indications Prostate cancer
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 30 May 2017 Planned End Date changed from 1 Apr 2017 to 1 May 2020.
- 30 May 2017 Planned primary completion date changed from 1 Oct 2016 to 1 May 2018.